IP Library Granted Patent US 8,071,789
Granted Patent B2
US 8,071,789 · App. 12/406,702 · Granted Dec 6, 2011

Synthetic molecules that specifically react with target sequences

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,071,789
App. No.
12/406,702
Granted
Dec 6, 2011
Kind
B2
Abstract

The present invention features biarsenical molecules. Target sequences that specifically react with the biarsenical molecules are also included. The present invention also features kits that include biarsenical molecules and target sequences. Tetraarsenical molecules are also featured in the invention.

Claims (24)

1. A kit comprising

a. a biarsenical molecule of the formula:

and tautomers, anhydrides, and salts thereof; and

b. a bonding partner comprising a target sequence and a carrier molecule, said target sequence comprising four cysteines capable of specifically reacting with said biarsenical molecule.

2. The kit of claim 1 , wherein said target sequence comprises a Cys-Cys-X-Y-Cys-Cys sequence, wherein said X and Y are amino acids.

3. The kit of claim 1 , wherein said target sequence is selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 4.

4. The kit of claim 1 , wherein said carrier molecule comprises a carrier polypeptide.

5. The kit of claim 4 , wherein said target sequence is heterologous to said carrier polypeptide.

6. The kit of claim 1 , wherein said biarsenical molecule specifically reacts with said target sequence and generates a detectable signal.

7. The kit of claim 6 , wherein said detectable signal is a fluorescent signal.

8. A kit comprising

a. a biarsenical molecule of the formula:

and tautomers, anhydrides, and salts thereof; and

b. a vector comprising a nucleic acid sequence encoding a target sequence, said nucleic acid sequence operatively linked to a promoter sequence and said target sequence comprising one or more cysteines capable of specifically reacting with said biarsenical molecule.

9. The kit of claim 8 , wherein said target sequence comprises four cysteines.

10. The kit of claim 8 , wherein said target sequence is selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 4.

11. The kit of claim 8 , wherein said vector further comprises a nucleic acid sequence encoding a carrier polypeptide.

12. The kit of claim 11 , wherein said carrier polypeptide is heterologous to said target sequence.

13. The kit of claim 8 , wherein said biarsenical molecule specifically reacts with said target sequence and generates a detectable signal.

14. The kit of claim 13 , wherein said detectable signal is a fluorescent signal.

15. A complex comprising a biarsenical molecule and a target sequence associated with a carrier polypeptide, said target sequence comprising one or more cysteines capable of reacting with said biarsenical molecule, said biarsenical molecule having the following formula:

and tautomers, anhydrides, and salts thereof.

16. The complex of claim 15 , wherein said target sequence comprises four cysteines.

17. The complex of claim 15 , wherein said target sequence is selected from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 4.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 12, 2020
From: UNIVERSITY OF CALIFORNIA SAN DIEGO
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 051801/0863 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2011
From: TSIEN, ROGER Y.; GRIFFIN, B. ALBERT
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 027163/0382 →
Continuity (6)
Continuation 11550275 · Oct 17, 2006
Continuation 10772164 · Feb 3, 2004
Continuation 10126752 · Apr 19, 2002
Continuation 09372338 · Aug 11, 1999
Continuation 08955859 · Oct 21, 1997
Related Publication 20100317097A1 · Dec 16, 2010